Novonesis share price logo

Novonesis

OTC: NVZMY

Large Cap

$66.20

+0.01

(+0.02%)

as on

Novonesis Stock Performance

as on November 18, 2026 at 7:58 am IST

  • Day's Low

    Day's High

    $66.19
    $66.78
    downward going graph

    0.02%

    Downside

    0.88%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Novonesis share price movements today

Previous Close
$66.19
Open
$66.39
Volume
60.4K
Market Cap
$31.6B
Dividend Yield
0.23%
Day's Low - High
$66.19 - $66.78

Novonesis Historical Returns

1 Month Return
-3.16 %
3 Month Return
+ 2.7 %
1 Year Return
+ 4.58 %
3 Year Return
+ 25.69 %
5 Year Return
0 %

Novonesis Stock Fundamentals & Key Indicators

Check Novonesis market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$31.6B

EPS (TTM)

1.49

Dividend Yield

0.23%

PE Ratio (TTM)

40.92

Industry PE ratio

20.99

PEG Ratio

1.51

Return On Equity TTM

6.17%

Novonesis vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Novonesis with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$31.6BNA40.9256.31%0.23%
StrongBuy$86.7B32.71%41.7443.94%0.94%
Buy$84.5B5.22%31.8748.69%0.91%
StrongBuy$241.5B57.92%34.7937.30%1.20%
StrongBuy$70.5B4.81%132.4431.58%2.28%

Stock Returns calculator for Novonesis Stock including INR - Dollar returns

The Novonesis stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Novonesis investment value today

Current value as on today

₹1,10,291

Returns

₹10,291

(+10.29%)

Returns from Novonesis Stock

₹4,598 (+4.6%)

Dollar Impact

₹5,693 (+5.69%)

Novonesis Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
914
1,000
-20,611
144
136
1,060
996
1,137
1,115
1,140
Gross Profit
383
613
-10,050
79
72
541
558
644
621
647
Operating Income
109
182
58
35
25
236
187
272
261
283
EBITDA
233
444
58
36
29
331
356
424
421
283
Interest Expense
3
18
4
2
2
14
16
8
30
-
Depreciation
124
135
166
144
154
146
177
152
160
-
Income Before Tax
44
163
43
32
23
170
152
261
221
242
Income Tax Expense
13
42
11
7
5
33
29
58
49
54
Net Income
31
120
32
24
18
137
-765
202
171
187
Net Profit Margin
41.87%
61.26%
48.76%
55.15%
53.46%
51.08%
56.07%
56.66%
55.73%
56.78%

Novonesis Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
14,531
14,390
14,374
14,012
14,951
17,553
17,899
513
4,157
Gross Profit
8,413
8,255
7,954
7,853
8,623
9,577
9,722
242
2,241
Operating Income
4,047
4,070
4,039
3,652
4,073
4,561
3,976
663
882
EBITDA
5,148
5,275
5,044
4,833
5,394
6,115
5,471
1,207
1,386
Interest Expense
27
36
113
63
102
154
23
76
9
Depreciation
1,028
1,027
1,159
1,249
1,368
1,457
1,389
544
574
Income Before Tax
3,876
3,936
3,799
3,521
4,091
4,556
3,909
55
743
Income Tax Expense
756
709
644
695
779
870
870
14
153
Net Income
3,119
3,226
3,154
2,825
3,146
3,676
3,024
40
583
Net Profit Margin
57.90%
57.37%
55.34%
56.04%
57.68%
54.56%
54.32%
47.20%
53.91%

Novonesis Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
31
120
241
186
136
137
122
202
174
187
Operating Cash Flow
263
245
491
106
320
3,458
328
169
364
374
Investing Cash Flow
-24
-45
-144
-38
-1,541
-1,591
-226
-94
-177
-125
Financing Cash Flow
-283
-203
-329
-102
1,309
-2,212
-102
-26
-210
-103
Change in Cash
48
22
19
-30
78
-348
-6
46
-21
146

Novonesis Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
3,120
3,227
3,155
2,826
3,145
3,686
3,024
305
583
Operating Cash Flow
4,063
3,679
3,196
4,355
4,062
4,006
4,152
1,019
1,221
Investing Cash Flow
-1,578
-1,392
-561
-1,524
-2,747
-2,672
-2,133
-199
-1,970
Financing Cash Flow
-2,664
-2,167
-2,644
-2,314
-1,586
-1,250
-1,889
-703
753
Change in Cash
-442
91
-12
470
-218
78
75
130
-4

Global Institutional Holdings in Novonesis

Check out the Institutions with significant holdings in Novonesis.

Funds
Holdings
ActivePassive
0.00%
SP Funds
0.00%
Avantis
0.00%

Insights on Novonesis

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.11B → 1.14B (in $), with an average increase of 2.2% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 171.60M → 187.89M (in $), with an average increase of 8.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, NVZMY stock has moved up by 2.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Linde plc Ordinary Shares has given 25.3% return, outperforming this stock by 20.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Ecolab, Inc. has given 28.3% return, outperforming this stock by 2.6%

About Novonesis

Novozymes A/S is a global biotechnology firm that specializes in the creation and distribution of industrial enzymes, microorganisms, and probiotics. Its operational footprint spans across Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific region. The company's broad range of products caters to numerous sectors: Food and Beverages: Supplying ingredients and processing aids for baking, a variety of beverages, dairy production, starch modification, and protein applications. Household Care: Delivering specialized formulations for laundry, dishwashing, and professional cleaning solutions. Agriculture: Providing innovations for crop cultivation, animal health and nutrition, alongside bioyield and biocontrol products for plant growth. Bioenergy and Industrial Processing: Offering critical components for grain and technical processing, encompassing liquefaction, saccharification, fermentation, fiber conversion, and biomass transformation. Textiles: Featuring technologies for biopreparation, biopolishing, bleach clean-up, denim abrasion and finishing, and desizing. Pulp and Paper: Enhancing processes through fiber modification, bleach boosting, deposit control, starch modification, and deinking agents. Leather Production: Furnishing treatments for acid bating, area expansion, general bating, degreasing, soaking, and unhairing/liming stages. Water and Waste Management: Contributing with bioaugmentation strategies, optimization of biogas production, and sludge management. Pharmaceuticals: Supplying specialized lipases (both free and immobilized), proteases for biocatalysis, and rTrypsin vital for cell culture applications. Furthermore, Novozymes provides offerings related to human health and various protein-based products. Founded in 1925, Novozymes A/S is headquartered in Bagsvaerd, Denmark.
OrganisationNovonesis
HeadquartersBiologiens Vej 2, Lyngby, ND, 2800, DK
IndustryChemicals - Specialty
CEOEster Baiget

Key Management of Novonesis

Name

Title

Ms. Ester Baiget

President & CEO

Mr. Rainer Lehmann

Executive VP & CFO

Mr. Claus Crone Fuglsang

Chief Scientific Officer

Mr. Tobias Cornelius Bjorklund

Head of Investor Relations

Mr. Tue Micheelsen

President of Novonesis North America & Head of Global Consumer Health

Mr. Andrew Taylor

Executive Vice President of Food & Beverage Biosolutions

Mr. Anders Lund

Chief Operating Officer

Mr. Morten Enggaard Rasmussen

Executive Vice President of People & Stakeholder Relations

Ms. Tina Sejersgaard Fano

Executive Vice President of Planetary Health Biosolutions

Mr. Henrik Joerck Nielsen

EVP of Human Health Biosolutions and Strategy & Integration

FAQs

What is Novonesis share price today?

Novonesis share price today is $66.20 as on at the close of the market. Novonesis share today touched a day high of $66.78 and a low of $66.19.

What is the 52 week high and 52 week low for Novonesis share?

Novonesis share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Novonesis stock price today i.e. is closed at $66.20,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Novonesis's market capitalisation today?

Novonesis market capitalisation is $0.03T as on .

How to invest in Novonesis Stock (NVZMY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Novonesis on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Novonesis Stock (NVZMY) from India?

Indian investors can start investing in Novonesis (NVZMY) shares with as little as ₹93.459999084473 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹934.60 in Novonesis stock (as per the Rupee-Dollar exchange rate as on ). Based on Novonesis share’s latest price of $66.20 as on November 18, 2026 at 2:28 am IST, you will get 0.1511 shares of Novonesis. Learn more about fractional shares .